UNSPSC 51111763: Soblidotin

This classification denotes a vinca-site binding agent and dolastatin compound with the molecular formula C39H67N5O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DQC51A0WQH, chemically known as n(2)-(n,n-dimethyl-valyl)-n-(2-methoxy-4-(2-(1-methoxy-2-methyl-3-oxo-3-((2-phenylethyl)amino)propyl)-1-pyrrolidinyl)-1-(1-methylpropyl)-4-oxobutyl)-n-methyl-valinamide but generally known as soblidotin, which bears US NIH Compound Identifier 124092.

UNSPSC 51111763 Soblidotin, a Commodity code, does not align with state and local procurement activity reflected in recent solicitations. The code nominally identifies a pharmaceutical active ingredient, yet the recent opportunities posted under this code cover naloxone procurement, medical and first aid supplies for emergency response, generic pharmaceuticals and OTC products through cooperative purchasing, and direct-to-manufacturer prescription program implementation — none of which involve soblidotin specifically. State and local governments soliciting under this code are acquiring finished pharmaceutical products, medical consumables, and pharmacy benefit program services rather than active pharmaceutical ingredients. The issuing bodies include county health departments (Seminole County, Florida), municipal fire and rescue divisions (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across participating jurisdictions including Oregon).

Recent opportunities span Florida, Texas, Minnesota, and Oregon, with activity distributed across health departments, emergency services, and pharmacy benefit administration. Representative solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (IFB60459723LAS, due July 26, 2023), the City of Tampa's sealed-bid procurement for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000.00 (26P00145, due March 13, 2026 and designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent SLBE bid discount not to exceed $10,000), the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026), and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescriptions (HHS0017013, posted April 3, 2026). The code shows little relevant recent activity in its stated pharmaceutical ingredient scope; the mismatch between the code's nominal taxonomy and the actual goods and services being bought suggests a classification error in the source data.